Search - tctmd.com

Displaying 781 - 800 of 976

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs

Yael L. Maxwell

November 16, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

Presentation AHA 2017

Impact of Regionalization of ST Elevation Myocardial Infarction Care

Presenter: James G. Jollis

November 14, 2017

News Conference News AHA 2017

Long-Awaited Hypertension Guidelines Released at AHA

Todd Neale

November 13, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Daily News

As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor

Todd Neale

October 26, 2017

News Daily News

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Caitlin E. Cox

October 24, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

Advertisement

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Impact of Regionalization of ST Elevation Myocardial Infarction Care

Long-Awaited Hypertension Guidelines Released at AHA

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Off Script: Welcome to TCT 2017 in the Mile High City

As Hypertension Sweeps China, Awareness, Treatment, and Control Remain Poor

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content